Molina Healthcare, Inc. (MOH) is an American managed care company that provides health insurance to people receiving government assistance. The company is headquartered in Long Beach, California and was founded in 1980 by an emergency room physician, Dr. C. David Molina, who noticed low-income, uninsured, or non-English speaking patients were frequently coming to the emergency room for general health care services primarily due to a lack of primary care physicians.
Molina Healthcare now contracts with state governments and serves as a health plan, providing a network of contracted physicians, clinics, hospitals, pharmacies, and ancillary service providers for Medicaid, Medicare, and other government-sponsored health insurance programs. The company focuses on individuals eligible for programs such as Medicaid (for low-income adults and children) and Medicare (for seniors and disabled people).
Since its inception, Molina Healthcare has extended its reach across the nation, serving millions of members through its health plans in 15 states across the United States. It has been lauded for its commitment to quality healthcare and the improvement of health outcomes for at-risk communities.
In addition to insurance, Molina Healthcare offers a range of health management programs, designed to improve the health of their members and reduce healthcare costs. These programs include coordinated care, disease management, health education, and promotion, utilization management, quality improvement, and pharmacy management.
Molina Healthcare's financial performance has been steady over the years, reinforcing their place as a stable and reliable health provider. Still, they continually strive to improve access and quality of healthcare services as part of their mission of serving vulnerable populations.
Also, Molina Healthcare values corporate responsibility. They engage in various community initiatives and strive for a diverse, inclusive workplace. Furthermore, they pay attention to their environmental impact by promoting sustainable practices.
The company’s approach underscores its commitment to providing high-quality care while addressing healthcare's socioeconomic aspects. As healthcare landscape continues to evolve against the backdrop of technological developments and policy upheavals, Molina Healthcare is positioned to navigate through these changes due to its long-standing experience serving vulnerable populations.
Income statement
Balance sheet statement
Cash flow statement
Current assets / Current liabilities
Equity / Debt / Cash
Dividends
UnitedHealth Group (NYSE:UNH) reported strong Q3 results on October 13, surpassing analyst forecasts for adjusted earnings per share and improving its medical care ratio. While total membership was slightly below expectations, reflecting a strategy to prioritize profitable business, the company raised its full-year earnings outlook. The positive report offers insights into the broader healthcare sector, though regulatory scrutiny and ongoing medical cost trends remain factors to monitor.
Shares of healthcare services company Agilon Health (AGL) surged 17.5% after reporting strong third-quarter 2026 earnings, swinging from a net loss to a net profit of $35 million and achieving significant revenue growth. The company also saw a recovery in adjusted EBITDA and a decline in its medical services expense ratio, indicating improved operating efficiency. Despite high volatility and a substantial year-to-date gain, the stock remains below its 52-week high.
Shares of Medicaid-focused U.S. health insurers and hospital operators saw significant gains in early trading after Democrats secured a sweeping victory in the midterm elections, taking control of both the Senate and House of Representatives. Analysts believe this outcome could delay or avoid the implementation of certain policy changes from President Donald Trump's "One Big Beautiful Bill" that were expected to reduce Medicaid enrollment and constrain state healthcare payments. This political shift is seen as easing pressure on Affordable Care Act insurers and hospital operators, and potentially improving prospects for extending enhanced subsidies.
Cerenome, through its subsidiary CNSide Diagnostics, has secured a national in-network agreement with Aetna Health Plans for its CNSide® Cerebrospinal Fluid (CSF) Tumor Cell Enumeration and Molecular Profile tests. This agreement, effective November 1, 2026, adds approximately 26 million Aetna members to CNSide’s contracted payer footprint, bringing their total covered lives to about 190 million (85% of private payers). This marks the first national CNSide payer agreement to cover both tumor cell enumeration and molecular profiling, enhancing patient access to critical diagnostic tests for CNS cancers.
Shares of Medicaid-focused US health insurers and hospital operators increased after Democrats secured a sweeping midterm election win. Analysts believe the Democratic victory could postpone or prevent the implementation of parts of President Donald Trump’s healthcare bill, which was expected to reduce Medicaid enrollment and limit state healthcare payments, thereby easing pressure on the sector. This outcome may also enhance prospects for extending enhanced subsidies for Affordable Care Act plans.
Healthcare investors are betting on a "Blue Wave" election outcome to benefit hospital operators, anticipating a reversal of Trump's Medicaid cuts. However, the article cautions against this assumption, reminding investors of past difficulties in rolling back healthcare agendas when an opposition party gained control. The piece suggests that such a reversal might be harder to achieve than markets currently anticipate.